Vbl Therapeutics (Nasdaq:Vblt)

Vbl Therapeutics (Nasdaq:Vblt) company information, Employees & Contact Information

VBL Therapeutics (Nasdaq: VBLT) is developing targeted therapies for immune-inflammatory diseases. VBL’s lead immunology product candidate VB-601 is a targeted antibody for immune-inflammatory applications expected to enter Phase 1 this year that has shown disease-modifying activity across multiple preclinical models including multiple sclerosis, rheumatoid arthritis and inflammatory bowel disease.

Company Details

Employees
14
Founded
-
Address
8 Hasatat St., Modiin,israel 7178106,israel
Phone
97236346450
Email
bu****@****lrx.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Modiin, Israel
Looking for a particular Vbl Therapeutics (Nasdaq:Vblt) employee's phone or email?

Vbl Therapeutics (Nasdaq:vblt) Questions

News

VBL Therapeutics and Notable Labs Announce Definitive Merger Agreement - GlobeNewswire

VBL Therapeutics and Notable Labs Announce Definitive Merger Agreement GlobeNewswire

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant